ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP16

Peer Health Coaches Help Scleroderma Patients Cope with Isolation

Mary Alore1, Yen Chen2 and Susan Murphy3, 1Troy, MI, 2University of Michigan, Ann Arbor, MI, 3University of Michigan, Plymouth, MI

Meeting: ACR Convergence 2023

Keywords: Fatigue, health behaviors, psychosocial factors, Scleroderma, Social support

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 12, 2023

Title: Patient Perspectives

Session Type: Patient Perspectives

Session Time: 4:00PM-5:00PM

Background/Purpose: In 2011, I felt extremely isolated with my new diagnosis of diffuse systemic sclerosis and sought support online and in support groups. In addition to being confusing, the misinformation I found about the disease was even scarier and more isolating than my diagnosis. I then sought social support through my rheumatologist at the University of Michigan who put me in contact with a few other patients who had asked him for similar social support. Since then, my focus has been on supporting and educating fellow scleroderma patients as a mentor. I have worked one-on-one with over 100 scleroderma patients and concluded that patients need peer support for their mental and physical wellbeing.

Intervention: In my work as a Peer Mentor with the Michigan Medicine Scleroderma Program, I received the opportunity to become a Peer Health Coach for the RENEW study. After meeting with 45 participants, I learned that almost all patients were lonely and isolated in their disease, just like I was ten years ago.

In addition to being diagnosed with scleroderma, you receive a new status – isolated. You’ve never heard of scleroderma prior to the diagnosis, nor has anyone you know. Also, the physicians you have been trying to get a diagnosis from over the last year are not familiar with scleroderma either. Plus, you get the reaction, “But you don’t look sick!” Through the RENEW study, health coaches met with patients virtually nine times over 12 weeks. Coaches led patients through goal-focused health-related learning modules and provided guidance, experience, and social support. As a health coach, I could offer real-life, lived experience and provide the support that was unavailable from family, friends, physicians, or therapists.

Maintenance: Patients need support and are seeking it. A trained health coach with a goal-setting framework helps them be less isolated and feel that they are not alone. Peer support is crucial for helping individuals change behaviors, like improving mental clarity and outlook, as well as motivating them to achieve health goals.

Quality of Life: I am able to discuss the health coaching experience from both the health coach and patient perspective to help reinforce the positive outcomes of peer social support. This is a valuable part of patient care that is missing in health systems.

Supporting image 1

RENEW Study logo


Disclosures: M. Alore: None; Y. Chen: None; S. Murphy: None.

To cite this abstract in AMA style:

Alore M, Chen Y, Murphy S. Peer Health Coaches Help Scleroderma Patients Cope with Isolation [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/peer-health-coaches-help-scleroderma-patients-cope-with-isolation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/peer-health-coaches-help-scleroderma-patients-cope-with-isolation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology